• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据对评估恶性风险至关重要的详细核特征,对意义未明的非典型性/AUS/意义未明的滤泡性病变病例进行细分是否有必要?

Is Subdivision of Atypia of Undetermined Significance AUS/Follicular Lesion of Undetermined Significance Cases According to Detailed Nuclear Features Vital for Assessing the Risk of Malignancy?

作者信息

Kaymaz Esin, Gun Banu Dogan, Tasdoven Ilhan, Kokturk Furuzan

机构信息

Department of Pathology, Faculty of Medicine, Zonguldak Bulent Ecevit Universtiy, Kozlu, Zonguldak, Turkey.

Department of General Surgery, Faculty of Medicine, Zonguldak Bulent Ecevit Universtiy, Kozlu, Zonguldak, Turkey.

出版信息

J Cytol. 2020 Oct-Dec;37(4):204-209. doi: 10.4103/JOC.JOC_5_20. Epub 2020 Nov 6.

DOI:10.4103/JOC.JOC_5_20
PMID:33776262
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7984522/
Abstract

BACKGROUND

It has been known that the "atypia of undetermined significance (AUS)/follicular lesion of undetermined significance (FLUS)" category is the most problematic category in Bethesda system due to its highly heterogeneous morphological features. Recently, it has been reported that aspirates including nuclear atypia in the AUS/FLUS category have a higher risk of malignancy.

AIMS

This study aimed to assess each nuclear property in aspirates with cytological atypia and also to determine the relationship with the risk of malignancy.

MATERIAL AND METHODS

We reviewed 980 AUS/FLUS fine-needle aspirations (FNAs) performed between '2012 and 2019' at a single institution. We classified these aspirates into four groups: AUS-N (nuclear atypia), AUS-A (architectural atypia), AUS-H (Hurthle cell change), and AUS-O (other). Nuclear features were detailed sub-classified; size and shape (enlargement, elongation, and overlapping), membrane irregularities (irregular contours, grooves, pseudoinclusion), and chromatin characteristics (pale chromatin). The estimated risk of malignancy (ROM) was calculated for each subgroup.

RESULTS

Of 980 AUS/FLUS cases, follow-up histological outcome data were available for 209 cases. Among these cases, the estimated ROM was 27.8%. The ROM were 26.4%, 15.4%, and 22.5% for AUS-N, A, and H, respectively. The most common nuclear findings associated with ROM were nuclear groove (67.9%); irregular contours (76.9%) suspected pseudoinclusion (100%) and overlapping (56%) ( < 0,001). But nuclear findings such as nuclear enlargement, mild pleomorphism, or pale chromatin have a similar ROM as architectural atypia.

CONCLUSION

Although it is known that the presence of cytological atypia in an AUS/FLUS nodule increases the estimated risk of malignancy, all nuclear properties are not equally effective in predicting malignancy risk. Emphasizing nuclear atypia details in reports of AUS case may be a more sensitive way to identify nodules with a high risk of malignancy.

摘要

背景

众所周知,“意义不明确的非典型性(AUS)/意义不明确的滤泡性病变(FLUS)”类别是贝塞斯达系统中最具问题的类别,因为其形态特征高度异质。最近,有报道称,AUS/FLUS类别中包括核非典型性的抽吸物具有更高的恶性风险。

目的

本研究旨在评估具有细胞学非典型性的抽吸物中的每种核特性,并确定其与恶性风险的关系。

材料与方法

我们回顾了2012年至2019年在单一机构进行的980例AUS/FLUS细针穿刺抽吸活检(FNA)。我们将这些抽吸物分为四组:AUS-N(核非典型性)、AUS-A(结构非典型性)、AUS-H(许特尔细胞改变)和AUS-O(其他)。核特征被详细地进一步分类;大小和形状(增大、伸长和重叠)、膜不规则(轮廓不规则、沟、假包涵体)和染色质特征(淡染色质)。计算每个亚组的估计恶性风险(ROM)。

结果

在980例AUS/FLUS病例中,有209例可获得随访组织学结果数据。在这些病例中,估计的ROM为27.8%。AUS-N、A和H组的ROM分别为26.4%、15.4%和22.5%。与ROM相关的最常见核表现为核沟(67.9%);轮廓不规则(76.9%)、疑似假包涵体(100%)和重叠(56%)(P<0.001)。但核增大、轻度多形性或淡染色质等核表现与结构非典型性的ROM相似。

结论

虽然已知AUS/FLUS结节中存在细胞学非典型性会增加估计的恶性风险,但并非所有核特性在预测恶性风险方面都同样有效。在AUS病例报告中强调核非典型性细节可能是识别具有高恶性风险结节的更敏感方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aefd/7984522/4fb47b97c4ec/JCytol-37-204-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aefd/7984522/cf45df403bd7/JCytol-37-204-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aefd/7984522/d3546ad6110c/JCytol-37-204-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aefd/7984522/4fb47b97c4ec/JCytol-37-204-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aefd/7984522/cf45df403bd7/JCytol-37-204-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aefd/7984522/d3546ad6110c/JCytol-37-204-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aefd/7984522/4fb47b97c4ec/JCytol-37-204-g003.jpg

相似文献

1
Is Subdivision of Atypia of Undetermined Significance AUS/Follicular Lesion of Undetermined Significance Cases According to Detailed Nuclear Features Vital for Assessing the Risk of Malignancy?根据对评估恶性风险至关重要的详细核特征,对意义未明的非典型性/AUS/意义未明的滤泡性病变病例进行细分是否有必要?
J Cytol. 2020 Oct-Dec;37(4):204-209. doi: 10.4103/JOC.JOC_5_20. Epub 2020 Nov 6.
2
Risk of malignancy according to sub-classification of the atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) category in the Bethesda system for reporting thyroid cytopathology.根据甲状腺细胞病理学报告的贝塞斯达系统中意义未明的非典型性或意义未明的滤泡性病变(AUS/FLUS)类别的亚分类情况,发生恶性肿瘤的风险。
Cytopathology. 2017 Feb;28(1):65-73. doi: 10.1111/cyt.12352. Epub 2016 Jun 1.
3
Subclassification of the Bethesda Category III (AUS/FLUS): A study of thyroid FNA cytology based on ThinPrep slides from the National Cancer Center in China.贝塞斯达分类法第 III 类(AUS/FLUS)的再分类:基于中国国家癌症中心 ThinPrep 切片的甲状腺细针抽吸细胞学研究。
Cancer Cytopathol. 2021 Aug;129(8):642-648. doi: 10.1002/cncy.22417. Epub 2021 Jun 17.
4
Clinico-cytopathological subcategorization in thyroid nodules of atypia of undetermined significance/follicular lesion of undetermined significance using the TIRADS and Bethesda classifications.应用 TIRADS 和 Bethesda 分类对甲状腺不典型意义结节/滤泡性病变不明意义的良恶性进行临床-细胞病理亚分类。
Front Endocrinol (Lausanne). 2023 May 29;14:1135196. doi: 10.3389/fendo.2023.1135196. eCollection 2023.
5
Two-tier subclassification of the Bethesda category III (atypia of undetermined significance/follicular lesion of undetermined significance) in thyroid cytology.甲状腺细胞学中 Bethesda 分类 III 级(意义不明确的非典型/意义不明确的滤泡性病变)的双层亚分类。
Diagn Cytopathol. 2024 Mar;52(3):156-162. doi: 10.1002/dc.25261. Epub 2023 Dec 14.
6
The risk of malignancy in the atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS) category subgroups: a Thai institute experience.AUS/FLUS 类别亚组中意义不明的非典型性/滤泡性意义不明病变的恶性肿瘤风险:泰国研究所的经验。
J Am Soc Cytopathol. 2024 Jan-Feb;13(1):16-22. doi: 10.1016/j.jasc.2023.09.006. Epub 2023 Sep 23.
7
Thyroid cytology-nuclear versus architectural atypia within the "Atypia of undetermined significance/follicular lesion of undetermined significance" Bethesda category have significantly different rates of malignancy.在“意义不明确的非典型性/意义不明确的滤泡性病变”这一贝塞斯达分类中,甲状腺细胞学检查——核非典型性与结构非典型性的恶性率存在显著差异。
Cancer Cytopathol. 2017 Apr;125(4):245-256. doi: 10.1002/cncy.21823. Epub 2017 Feb 13.
8
Outcome of atypia of undetermined significance/follicular lesion of undetermined significance in thyroid fine-needle aspirations: A six-year institutional experience.甲状腺细针抽吸标本中意义不明的非典型性/滤泡性病变的结局:六年机构经验。
Diagn Cytopathol. 2021 Aug;49(8):915-920. doi: 10.1002/dc.24771. Epub 2021 May 11.
9
An institutional experience: A retrospective analysis of the effect of transitioning from follicular lesion of undetermined significance to atypia of undetermined significance with subclassified atypia on interobserver concordance, rates of neoplasia, and rates of malignancy.机构经验:回顾性分析从滤泡性意义未明病变到意义未明不典型增生并细分不典型增生对观察者间一致性、肿瘤发生率和恶性率的影响。
Diagn Cytopathol. 2021 Jan;49(1):31-38. doi: 10.1002/dc.24611. Epub 2020 Sep 16.
10
An Insight into the Utility of Sub-Categorisation of Atypia of Undetermined Significance for Risk Stratification: A Retrospective Study on an Indian Cohort with Histopathological Correlation.非典型意义未明的亚分类在风险分层中的效用洞察:一项对具有组织病理学相关性的印度队列的回顾性研究
Acta Cytol. 2019;63(3):182-188. doi: 10.1159/000496600. Epub 2019 Mar 19.

引用本文的文献

1
Subclassifying "Atypia of Undetermined Significance (AUS)" Category in the 2023 Bethesda System for Thyroid Cytopathology: Analyzing K-TIRADS, BRAF V600E Mutation, and Risk of Malignancy.2023年甲状腺细胞病理学贝塞斯达系统中“意义未明的非典型性(AUS)”类别的亚分类:分析K-TIRADS、BRAF V600E突变和恶性风险
Endocr Pathol. 2025 Apr 15;36(1):12. doi: 10.1007/s12022-025-09856-1.
2
Proposal for Clinical Management of Nodules Diagnosed as Atypia of Undetermined Significance via Thyroid Fine-Needle Aspiration Cytology in the Absence of Molecular Testing.在缺乏分子检测的情况下,关于通过甲状腺细针穿刺细胞学诊断为意义未明的非典型性结节的临床管理建议。
Cytopathology. 2025 Mar;36(2):115-122. doi: 10.1111/cyt.13467. Epub 2025 Jan 10.
3

本文引用的文献

1
A Proposal for Separation of Nuclear Atypia and Architectural Atypia in Bethesda Category III (AUS/FLUS) Based on Differing Rates of Thyroid Malignancy.基于甲状腺恶性肿瘤不同发生率的 Bethesda 分类系统Ⅲ类(AUS/FLUS)中核异型和结构异型的分离建议
Am J Clin Pathol. 2019 Jan 1;151(1):86-94. doi: 10.1093/ajcp/aqy109.
2
Cancer Risk Associated with Nuclear Atypia in Cytologically Indeterminate Thyroid Nodules: A Systematic Review and Meta-Analysis.核异型性在细胞学不确定的甲状腺结节中与癌症风险的相关性:系统评价和荟萃分析。
Thyroid. 2018 Feb;28(2):210-219. doi: 10.1089/thy.2017.0419. Epub 2017 Dec 21.
3
Comparison of risk of malignancy in a subgroup with atypia of undetermined significance/follicular lesion of undetermined significance: A meta-analysis.
A Comprehensive Approach to the Thyroid Bethesda Category III (AUS) in the Transition Zone Between 2nd Edition and 3rd Edition of The Bethesda System for Reporting Thyroid Cytopathology: Subcategorization, Nuclear Scoring, and More.
《贝塞斯达系统报告甲状腺细胞病理学》第 2 版和第 3 版之间过渡区域甲状腺贝塞斯达类别 III(AUS)的综合方法:细分、核评分及更多。
Endocr Pathol. 2024 Mar;35(1):51-76. doi: 10.1007/s12022-024-09797-1. Epub 2024 Jan 27.
4
The Role of "Critical" Ultrasound Reassessment in the Decision-Making of Bethesda III Thyroid Nodules.“临界”超声再评估在 Bethesda III 甲状腺结节决策中的作用。
Medicina (Kaunas). 2023 Aug 17;59(8):1484. doi: 10.3390/medicina59081484.
5
Predictors of Malignancy in Thyroid Nodules Classified as Bethesda Category III.甲状腺结节 Bethesda 分类为 III 类的恶性肿瘤预测因素。
Front Endocrinol (Lausanne). 2022 Feb 16;13:806028. doi: 10.3389/fendo.2022.806028. eCollection 2022.
意义不明确的非典型性/意义不明确的滤泡性病变亚组中恶性肿瘤风险的比较:一项荟萃分析。
Head Neck. 2017 Aug;39(8):1699-1710. doi: 10.1002/hed.24768. Epub 2017 May 11.
4
Risk of malignancy according to sub-classification of the atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) category in the Bethesda system for reporting thyroid cytopathology.根据甲状腺细胞病理学报告的贝塞斯达系统中意义未明的非典型性或意义未明的滤泡性病变(AUS/FLUS)类别的亚分类情况,发生恶性肿瘤的风险。
Cytopathology. 2017 Feb;28(1):65-73. doi: 10.1111/cyt.12352. Epub 2016 Jun 1.
5
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.包膜滤泡型甲状腺乳头状癌命名法修订:减少惰性肿瘤过度治疗的范式转变。
JAMA Oncol. 2016 Aug 1;2(8):1023-9. doi: 10.1001/jamaoncol.2016.0386.
6
Cytologic subclassification of atypia of undetermined significance may predict thyroid nodules more likely to be malignant at surgery.意义未明的非典型细胞学分型可能预测甲状腺结节在手术时更有可能为恶性。
Diagn Cytopathol. 2016 Jun;44(6):492-8. doi: 10.1002/dc.23472. Epub 2016 Mar 30.
7
The Impact of Noninvasive Follicular Variant of Papillary Thyroid Carcinoma on Rates of Malignancy for Fine-Needle Aspiration Diagnostic Categories.甲状腺乳头状癌非侵袭性滤泡变体对细针穿刺诊断分类恶性率的影响
Thyroid. 2015 Sep;25(9):987-92. doi: 10.1089/thy.2014.0612. Epub 2015 Jul 29.
8
Malignancy risk and reproducibility associated with atypia of undetermined significance on thyroid cytology.甲状腺细胞病理学中意义不明确的非典型病变相关的恶性风险及可重复性。
Surgery. 2014 Dec;156(6):1471-6; discussion1476. doi: 10.1016/j.surg.2014.08.026. Epub 2014 Sep 11.
9
Thyroid atypia of undetermined significance or follicular lesion of undetermined significance: an indispensable Bethesda 2010 diagnostic category or waste garbage?意义未明的甲状腺非典型病变或意义未明的滤泡性病变:2010年《贝塞斯达系统》中不可或缺的诊断类别还是无用之物?
Acta Cytol. 2014;58(4):319-29. doi: 10.1159/000366498. Epub 2014 Sep 2.
10
Should the thyroid AUS/FLUS category be further stratified by malignancy risk?甲状腺AUS/FLUS类别是否应根据恶性风险进一步分层?
Cancer Cytopathol. 2014 Jul;122(7):481-3. doi: 10.1002/cncy.21412. Epub 2014 Mar 13.